The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy.

MedStar author(s):
Citation: Mayo Clinic Proceedings. 96(10):2511-2513, 2021 10.PMID: 34607632Institution: MedStar Heart & Vascular Institute | MedStar Washington Hospital CenterDepartment: Cardiovascular Disease FellowshipForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: *Cardiovascular Diseases | *Proton Pump Inhibitors | Cardiovascular Diseases/ci [Chemically Induced] | Cardiovascular Diseases/ep [Epidemiology] | Heart Disease Risk Factors | Humans | Polypharmacy | Proton Pump Inhibitors/ae [Adverse Effects] | Risk FactorsYear: 2021ISSN:
  • 0025-6196
Name of journal: Mayo Clinic proceedingsAll authors: Malik N, Weintraub WSOriginally published: Mayo Clinic Proceedings. 96(10):2511-2513, 2021 Oct.Fiscal year: FY2022Fiscal year of original publication: FY2022Digital Object Identifier: Date added to catalog: 2021-11-01
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 34607632 Available 34607632


Powered by Koha